University of Ioannina
Speech difficulties and dysphagia in Parkinson's disease and their neuroimaging correlates
Abstract
dc:descriptionSpeech disorders and dysphagia are common and functionally significant symptoms of Parkinson’s disease (PD), yet their onset and underlying mechanisms in the early stages of the disease remain poorly understood. Understanding how these disorders relate to clinical, neurodegenerative, and dopaminergic markers is crucial for improving early diagnosis and intervention. This thesis aimed to: (1) describe and compare demographic and clinical characteristics, cerebrospinal fluid (CSF) biomarker levels, and presynaptic dopaminergic deficits in early-stage PD patients—both treatment-naïve and levodopa-treated—with and without speech disorders; and (2) describe and compare the same variables in patients with and without dysphagia.Data were obtained from the Parkinson’s Progression Markers Initiative (PPMI) database. Participants were categorised based on treatment status (treatment-naïve vs. levodopa-treated) and the presence or absence of speech disorders and/or dysphagia. Group comparisons and logistic regressions were conducted using clinical scales (MDS-UPDRS, Hoehn & Yahr, MoCA), CSF biomarkers (alpha-synuclein, amyloid-beta, total tau, phosphorylated tau), and DAT-SPECT imaging of presynaptic dopaminergic function (binding in the putamen and caudate). Speech disorders were significantly associated with greater motor severity and reduced dopaminergic activity in the putamen. In contrast, dysphagia was primarily associated with dopaminergic deficits in the caudate in treatment-naïve patients, and with elevated CSF tau and pTau levels in levodopa-treated patients. Neither speech disorders nor dysphagia were significantly predicted by age or sex. Cognitive impairment was associated with speech disorders but was not a consistent predictor of dysphagia.Speech and swallowing impairments in early PD reflect complex interactions between motor, cognitive, and neurodegenerative processes. Dopaminergic deficits -particularly within striatal regions- contribute to both symptoms; however, distinct mechanisms, such as tau pathology and region-specific dopamine loss, may underpin their manifestation at different disease stages and treatment phases. These findings highlight the need for early, targeted, and multidimensional assessment approaches to optimise clinical management and support the development of personalised interventions for communication and swallowing disorders in PD.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Polychronis, Sotirios
- Πολυχρόνης, Σωτήριος
Subjects
dc:subject × 16- Νόσος του Πάρκινσον
- Διαταραχές ομιλίας
- Δυσφαγία
- Ντοπαμινεργικό Έλλειμμα
- Βιοδείκτες Εγκεφαλονωτιαίου Υγρού
- Parkinson's disease
- Speech difficulties
- Dysphagia
- Dopaminergic deficit
- Cerebrospinal fluid biomarkers
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επαγγέλματα υγείας
- Health Sciences
- Medical and Health Sciences
- Health Professions
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60239